TrialGut2009

A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease.

C Keywood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.